Raymond E, Chaney SG, Taamma A, et al. Oxaliplatin:a review of preclinical and clinical studies.[J] Ann Oncol,1998, 9:1053-1071.
[2]
De Gramont A, Figer A, SeymonrM, et al. Leucovorin and fluorouracil with or without oxaliplatin as frist-line treatment in advanced colorectal cancer. J Clin Oncol, 2000,18:2938-2947.
[3]
蔡三军.结直肠肛管癌[ M].北京:北京大学出版社,2006:287-298.
[4]
SumpterK, HarperWynne C, Cunningham D, et al. Report of two protocol planned interim analysis in a randomized multicentre phaseⅢstudy comparing capecitabinewith fluorouracil and oxali-platin with cisplatin in patients with advanced esophagogastric cancer receiving ECF [ J]. Br J Cancer, 2005, 92(11):1976-1983.
ParkY,Lee J,Ryoo B, et al. A phaseⅡstudy of capecitabine plus oxaliplatin(XELOX)as first-line therapy for patients with ad-vanced gastric cancer(Abst)[J]. Proc Am Soc Clin Oncol, 2006:4079.
